gmpnews-1-2017-annonceRussian Magazine for the Leaders of Pharmaceutical Industry
Subscribe for free!
(In Russian)

TOP News

Vialek Book Banner

Roszdravnadzor detected and recalled 2 counterfeit drugs in H1

fake drugs
The Federal Service for Surveillance in Healthcare released the results of state control (surveillance) over the circulation of medicinal products for H1 2017

Bacteriophage medications may become the substitutes for antibiotics

The Institute of Chemical Biology and Fundamental Medicine of SB of RAS is developing a new generation of therapeutic bacteriophage medications that represent a soft and safe alternative to antibiotics

Domestic demand falls while pharmaceutical production is growing in Kazakhstan

Consumers in Kazakhstan spend less money on their health – in the past 5 years, the sales of vitamins and pro-vitamins in the country fell by 6 times; and sales of antibiotics dropped by 31%

Avista Healthcare teams up with Envigo CRO

Avista Healthcare Public Acquisition Corp., a publicly traded special purpose acquisition company, and Envigo International Holdings, Inc., a leading early stage non-clinical contract research organization

Micro-Sphere invests €19 million in enhancement of its GMP facility

drugs quality control
Spray drying specialist and capsule filling service provider Micro-Sphere is investing €19 million into expanding its GMP manufacturing capabilities at its facility in Switzerland

Dr Reddy’s out-licensed rights for a drug to US pharmaceutical company

dr reddys
Dr Reddy's Labs announced that it has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc.

National Cancer Center of Japan sets up a new drug development system

Japan's National Cancer Center will establish a system for cooperating on the development of cancer drugs with four medical institutions in South Korea, Taiwan, Singapore and Hong Kong

Subscribe to GMP news Newsletter!

Pharmcontract Banner


National producers entered the market with nearly a dozen of biosimilars

Denis Manturov
Denis Manturov told the correspondent of "Expert" magazine how the Ministry for Industry & Trade continues to work towards technical upgrading of the Russian industry, about current progress in th...

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...

Modern Russian enterprises are not inferior in terms of quality to the foreign facilities

The 19th International Exhibition of equipment, raw materials and technologies for pharmaceutical production – Pharmtech & Ingredients 2016 – was held on November 22-25, 2016.   On the first da...

Subscribe to GMP news Newsletter!